XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Balance beginning (in shares) at Dec. 31, 2019   32,399,352        
Balance beginning at Dec. 31, 2019 $ (186,017) $ 324 $ 1,260,551 $ (1,431,801) $ (2,583) $ (12,508)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred stock beneficial conversion feature 0   24,139 (24,139)    
Conversion of preferred stock (in shares)   4,388,850        
Conversion of preferred stock 199,822 $ 44 199,778      
Stock-based compensation 128,035   128,035      
Stock issued under incentive programs (in shares)   2,168,725        
Stock issued under incentive programs 5,246 $ 22 44,447   (39,223)  
Issuance of common stock, net of issuance costs (in shares)   32,393,438        
Issuance of common stock, net of issuance costs 878,850 $ 324 878,526      
Unrealized gain (loss) on marketable securities 9         9
Foreign currency translation adjustment 19,523         19,523
Net loss (418,259)     (418,259)    
Balance ending (in shares) at Dec. 31, 2020   71,350,365        
Balance ending at Dec. 31, 2020 627,209 $ 714 2,535,476 (1,874,199) (41,806) 7,024
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 183,626   183,626      
Stock issued under incentive programs (in shares)   2,503,819        
Stock issued under incentive programs 24,761 $ 24 68,032   (43,295)  
Issuance of common stock, net of issuance costs (in shares)   2,578,967        
Issuance of common stock, net of issuance costs 564,859 $ 26 564,833      
Unrealized gain (loss) on marketable securities (9)         (9)
Foreign currency translation adjustment (8,368)         (8,368)
Net loss (1,743,751)     (1,743,751)    
Balance ending (in shares) at Dec. 31, 2021   76,433,151        
Balance ending at Dec. 31, 2021 (351,673) $ 764 3,351,967 (3,617,950) (85,101) (1,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 131,967   131,967      
Stock issued under incentive programs (in shares)   701,005        
Stock issued under incentive programs (639) $ 7 4,912   (5,558)  
Issuance of common stock, net of issuance costs (in shares)   9,672,398        
Issuance of common stock, net of issuance costs 249,230 $ 97 249,133      
Foreign currency translation adjustment (5,024)         (5,024)
Net loss (657,939)     (657,939)    
Balance ending (in shares) at Dec. 31, 2022   86,806,554        
Balance ending at Dec. 31, 2022 $ (634,078) $ 868 $ 3,737,979 $ (4,275,889) $ (90,659) $ (6,377)